Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | NR4A2 | P43354 | 4/20 | 0.52 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.47 |
| ▸ | WNT3A | P56704 | 3/20 | 0.47 |
| ▸ | ASH1L | Q9NR48 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.45 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2807419 | 0.90 | GPR84 (0.54) | NPC1NR4A2MAPTCTNNB1WNT3A | |
| SCHEMBL3243814 | 0.85 | MAPT (0.67) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL7416222 | 0.85 | NPC1 (0.64) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL10981308 | 0.84 | NPC1 (0.56) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL10984173 | 0.84 | NPC1 (0.56) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL10989463 | 0.84 | NPC1 (0.56) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL10984972 | 0.84 | NPC1 (0.56) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL10981435 | 0.84 | NPC1 (0.56) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL10983460 | 0.84 | NPC1 (0.56) | NPC1NR4A2EIF2AK2MAPTASH1L | |
| SCHEMBL10982974 | 0.84 | NPC1 (0.56) | NPC1NR4A2EIF2AK2MAPTASH1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0820441-B1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-06-26 | — | — | EP | disclosed |
| US-6358992-B1 | Method of inhibiting neoplastic cells with indole derivatives | CELL PATHWAYS, INC. | 2002-03-19 | — | — | US | disclosed |
| US-6069156-A | Indole derivatives as cGMP-PDE inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-30 | — | — | US | disclosed |
| CN-1187812-A | Indole derivatives as CGMP-PDE inhibitors | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-07-15 | — | — | CN | disclosed |
| EP-0820441-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996032379-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-17 | — | — | WO | disclosed |